Stellaromics

Boston, MA · Founded 2022 · Privately Held (backing)

Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. Stellaromics is based in Boston, MA and was founded in 2022. Its last reported valuation was $163 million in Dec 2024. It has raised $105 million.

Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$105.0M
Last round
—

Who backs Stellaromics?

5 investors
InvestorType
Stanford University Venture Fund—
Bayshore Global ManagementFamily office
Catalyst4—
Falcon Creek Capital—
Plaisance Capital Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stellaromics investors

5 investors are on record for Stellaromics, including Stanford University Venture Fund, Bayshore Global Management, Catalyst4 and Falcon Creek Capital.

Free account
More of Stellaromics with a free account
  • ·Watch Stellaromics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Stellaromics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View